Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Center, Open, Phase I Clinical Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Leukemia

NCT02968472 is registered in ClinicalTrials.gov with The First People's Hospital of Yunnan as lead sponsor.

NCT NCT02968472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02968472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Center, Open, Phase I Clinical Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Leukemia
Lead sponsor
The First People's Hospital of Yunnan
Phase
Phase 1
Overall status
Unknown status
Start date
March 31, 2015
Completion date
May 31, 2019
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

b acute lymphoblastic leukemia